Mesothelioma, a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos is considered one of the most aggressive of all cancers.
Washington, DC (PRWEB) June 22, 2011
The 8th annual International Symposium on Malignant Mesothelioma, taking place in Washington, DC on June 23-25, and organized by the Mesothelioma Applied Research Foundation (Meso Foundation), is the only conference of its kind that brings together mesothelioma scientists, doctors, medical professionals, mesothelioma patients and their families, and other advocates interested in curing mesothelioma.
The Meso Foundation has assembled an exceptional agenda of topics which will be presented by well-known experts in the fields of mesothelioma and health. A full agenda is available at http://www.curemeso.org/symposium.
“The Meso Foundation’s annual Symposium is one of the most effective and practical ways for patients and their families to gain insight into this very rare disease, and obtain information directly from the experts all in one place at the same time,” said Kathy Wiedemer, Executive Director of the Meso Foundation.
“But this conference is not just for patients. It is also an opportunity for researchers and treating physicians to come together to share and compare information – this is the kind of information-sharing that is crucial in ensuring expedient progress in the development of treatments for mesothelioma,” she added.
Mesothelioma, a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos is considered one of the most aggressive of all cancers. Approximately 3,000 Americans are diagnosed with mesothelioma every year, yet available treatments have limited effectiveness.
During the 2011 International Symposium on Malignant Mesothelioma, the Meso Foundation will honor three individuals who, each in their own way, have made significant contributions to the fight against mesothelioma.
This year’s honorees include Dr. Raffit Hassan, Senior Investigator and Chief of the Solid Tumor Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute (NCI) and former Chair of the Meso Foundation’s Science Advisory Board; Larry Davis, mesothelioma patient and dedicated Meso Foundation volunteer fundraiser; and Linda Reinstein, the co-founder of the Asbestos Disease Awareness Organization (ADAO).
ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the leading organization dedicated to funding peer-reviewed mesothelioma research, providing patient support services and education, and advocating for increased federal funding for research. Mesothelioma funding, per death, has historically been extremely low, and even as recently as 2007, the NCI reported that mesothelioma receives as little as 9 times less funding than other cancers. The Meso Foundation was founded in 2000 to address this imbalance and since then has funded over $7.1 million in peer-reviewed mesothelioma research.